Cy3
Precision Medicine in Cardiovascular Disease: Genetics and Impact on Phenotypes: JACC Focus Seminar 1/5
Our understanding of the genetic foundation of cardiovascular illnesses (CVDs) has developed quickly. This has resulted from a mixture of devoted analysis in effectively phenotyped CVD sufferers, the sequencing of the human genome, and the prepared accessibility and reducing value of next-generation sequencing applied sciences. This elevated data of the genetic foundation of CVDs has heralded the period of precision medication.
This encompasses many parts together with improved analysis, household screening, help with reproductive choices, focused therapeutics guided by each phenotype and genotype, and offering necessary insights into threat stratification and prognosis. Moreover, novel insights into genetic mechanisms, medical rollout of polygenic threat scores for frequent CVDs, and the promise of genome enhancing approaches to successfully remedy illness symbolize a few of the thrilling future endeavors that can change established medical approaches. This Half 1 of a 5-part collection focuses on the underpinnings and elementary elements of precision medication.
Triggers of Cardiovascular Ailments in Rheumatoid Arthritis
The danger of heart problems (CVD) in sufferers with rheumatoid arthritis (RA) is greater than that in sufferers with out RA, and it’s even greater than that in sufferers with diabetes. Autoimmune-mediated irritation is noticed in sufferers with RA, leading to endothelial dysfunction, oxidative stress and activation, and vascular migration of white blood cells. Historically, RA-associated CVD was assumed to be mediated by disease-related irritation, leading to atherosclerosis (AS). Nevertheless, this idea has been challenged as a result of remedy with anti-rheumatic medication, resembling methotrexate or proinflammatory cytokine antagonists, resembling tumor necrosis factor-alpha (TNF-α) inhibitors, didn’t scale back the chance of CVD in sufferers with RA.
Present cardiovascular tips advocate screening and remedy of CVD threat components in sufferers with RA however with out clear biomarkers and remedy targets. There is no such thing as a scientific foundation for establishing therapeutic targets for cardiovascular threat components in RA. Quite a few research have proven that the mechanism of early cardiac dysfunction in sufferers with RA could happen previous to AS. Subsequently, it’s essential to discover the associated mechanisms to stop early cardiac dysfunction in sufferers with RA.
Major sclerosing cholangitis and the chance of most cancers, cardiovascular illness, and all-cause mortality: a scientific evaluation and meta-analysis of cohort research
A analysis of major sclerosing cholangitis (PSC) has been related to elevated threat of hepatobiliary cancers, colorectal most cancers and all-cause mortality in a number of research, whereas associations with heart problems have been inconsistent. We carried out a scientific evaluation and meta-analysis of revealed cohort research on the subject to summarize these associations. PubMed and Embase databases had been searched as much as January 13th, 2020.
Cohort research on PSC and threat of most cancers, heart problems, or mortality had been included. Abstract relative dangers (RRs) and 95% confidence intervals (95% CIs) had been estimated utilizing random results fashions. The abstract RR (95% CI) evaluating individuals with PSC to individuals with out PSC was 584.37 (269.42-1267.51, I2 = 89%, n = 4) for cholangiocarcinoma (CCA), 155.54 (125.34-193.02, I2 = 0%, n = 3) for hepatobiliary most cancers, 30.22 (11.99-76.17, I2 = 0%, n = 2) for liver most cancers, 16.92 (8.73-32.78, I2 = 88%, n = 4) for gastrointestinal most cancers, 7.56 (2.42-23.62, I2 = 0%, n = 3) for pancreatic most cancers, 6.10 (4.19-8.87, I2 = 14%, n = 7) for colorectal most cancers (CRC), 4.13 (2.99-5.71, I2 = 80%, n = 5) for complete most cancers, 3.55 (2.94-4.28, I2 = 46%, n = 5) for all-cause mortality, and 1.57 (0.25-9.69, I2 = 79%, n = 2) for heart problems.

Robust optimistic associations had been noticed between PSC and threat of CCA, hepatobiliary most cancers, liver most cancers, gastrointestinal most cancers, pancreatic most cancers, CRC, complete most cancers, and all-cause mortality, however not for heart problems.
Cardiovascular Illness and Psychological Misery Amongst Ethnic Teams in Kyrgyzstan
The aim of this research was to characterize totally different ethnic teams in Kyrgyzstan concerning heart problems (CVD) and psychological misery, and to analyze the affiliation between CVD and psychological misery. The psychological misery was measured when it comes to sleep disturbance, burnout, and stress. Supplies and Strategies: A cross-sectional research was carried out amongst six ethnic teams in Kyrgyzstan, aged 18 years and above.
The pattern was stratified for age, training, household standing, and earnings. We used the Karolinska Sleep Questionnaire to evaluate sleep disturbance, the bodily and emotional subscale of the Shirom Melamed Burnout Questionnaire to evaluate burnout, and the 10-item Perceived Stress Scale to evaluate perceived stress. Outcomes: The distribution of CVD differed considerably between the six ethnic teams, with greater prevalence amongst East Europeans, and Western Asians and decrease amongst Different minorities and Central Asians.
HSPB7 Antibody |
|||
| DF2506-100ul | Affinity Biosciences | 100ul | EUR 168 |
|
Description: WB,ELISA(peptide) |
|||
HSPB7 Antibody |
|||
| DF2506-200ul | Affinity Biosciences | 200ul | EUR 210 |
|
Description: WB,ELISA(peptide) |
|||
HSPB7 Antibody |
|||
| C44144-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: HSPB7 Rabbit Polyclonal Antibody |
|||
HSPB7 Antibody |
|||
| C44144-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: HSPB7 Rabbit Polyclonal Antibody |
|||
HSPB7 Antibody |
|||
| 1-CSB-PA10979A0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against HSPB7. Recognizes HSPB7 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
Hspb7 Antibody |
|||
| GWB-MN894C | GenWay Biotech | 50ug | Ask for price |
Hspb7 Antibody |
|||
| GWB-MN895D | GenWay Biotech | 50ug | Ask for price |
HSPB7 Antibody |
|||
| E94645 | EnoGene | 100μg | EUR 255 |
|
Description: Available in various conjugation types. |
|||
HSPB7 Antibody |
|||
| MBS1491847-005mg | MyBiosource | 0.05mg | EUR 190 |
HSPB7 Antibody |
|||
| MBS1491847-01mg | MyBiosource | 0.1mg | EUR 270 |
HSPB7 Antibody |
|||
| MBS1491847-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
HSPB7 Antibody |
|||
| MBS9604020-01mL | MyBiosource | 0.1mL | EUR 260 |
HSPB7 Antibody |
|||
| MBS9604020-02mL | MyBiosource | 0.2mL | EUR 305 |
HSPB7 Antibody |
|||
| MBS9604020-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
HSPB7 Antibody |
|||
| MBS8500142-01mg | MyBiosource | 0.1mg | EUR 325 |
HSPB7 Antibody |
|||
| MBS8500142-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
HSPB7 Antibody |
|||
| MBS8500142-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
HSPB7 Antibody |
|||
| MBS8500142-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
HSPB7 Antibody |
|||
| MBS8500142-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
Hspb7 antibody |
|||
| 70R-8510 | Fitzgerald Industries International | 50 ug | Ask for price |
Hspb7 antibody |
|||
| 70R-8511 | Fitzgerald Industries International | 50 ug | Ask for price |
HSPB7 antibody |
|||
| 70R-17847 | Fitzgerald Industries International | 50 ul | Ask for price |
HSPB7 Rabbit pAb |
|||
| A18450 | Abclonal | 500μL | EUR 1246.96 |
HSPB7 Rabbit pAb |
|||
| A18450-100ul | Abclonal | 100 ul | EUR 369.6 |
HSPB7 Rabbit pAb |
|||
| A18450-200ul | Abclonal | 200 ul | EUR 550.8 |
HSPB7 Rabbit pAb |
|||
| A18450-20ul | Abclonal | 20 ul | EUR 219.6 |
HSPB7 Rabbit pAb |
|||
| A18450-50ul | Abclonal | 50 ul | EUR 267.6 |
HSPB7 cDNA Clone |
|||
| MBS1266057-001mgPlasmid02mLGlycerolStock | MyBiosource | 0.01mgPlasmid+0.2mLGlycerol-Stock | EUR 200 |
HSPB7 cDNA Clone |
|||
| MBS1266057-5x001mgPlasmid5x02mLGlycerolStock | MyBiosource | 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock | EUR 855 |
HSPB7 Rabbit pAb |
|||
| E45R29847N | EnoGene | 50 ul | EUR 297.75 |
HSPB7 Rabbit pAb |
|||
| MBS9143343-002mL | MyBiosource | 0.02mL | EUR 200 |
HSPB7 Rabbit pAb |
|||
| MBS9143343-005mL | MyBiosource | 0.05mL | EUR 255 |
HSPB7 Rabbit pAb |
|||
| MBS9143343-01mL | MyBiosource | 0.1mL | EUR 345 |
HSPB7 Rabbit pAb |
|||
| MBS9143343-02mL | MyBiosource | 0.2mL | EUR 545 |
HSPB7 Rabbit pAb |
|||
| MBS9143343-5x02mL | MyBiosource | 5x0.2mL | EUR 2265 |
Mouse HSPB7 siRNA |
|||
| 20-abx919996 | Abbexa |
|
|
Human HSPB7 siRNA |
|||
| 20-abx919997 | Abbexa |
|
|
HSPB7 siRNA (Human) |
|||
| MBS8234979-15nmol | MyBiosource | 15nmol | EUR 405 |
HSPB7 siRNA (Human) |
|||
| MBS8234979-30nmol | MyBiosource | 30nmol | EUR 565 |
HSPB7 siRNA (Human) |
|||
| MBS8234979-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
HSPB7 siRNA (Mouse) |
|||
| MBS8215075-15nmol | MyBiosource | 15nmol | EUR 405 |
HSPB7 siRNA (Mouse) |
|||
| MBS8215075-30nmol | MyBiosource | 30nmol | EUR 565 |
HSPB7 siRNA (Mouse) |
|||
| MBS8215075-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
anti- HSPB7 antibody |
|||
| FNab04060 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against HSPB7 |
|||
HSPB7 cloning plasmid |
|||
| CSB-CL890668HU-10ug | Cusabio | 10ug | EUR 279.6 |
|
Description: A cloning plasmid for the HSPB7 gene. |
|||
HSPB7 Blocking Peptide |
|||
| DF2506-BP | Affbiotech | 1mg | EUR 234 |
HSPB7 Blocking Peptide |
|||
| MBS9622737-1mg | MyBiosource | 1mg | EUR 380 |
HSPB7 Blocking Peptide |
|||
| MBS9622737-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
Recombinant Human HSPB7 |
|||
| MBS7611589-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human HSPB7 |
|||
| MBS7611589-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human HSPB7 |
|||
| MBS7611589-1mg | MyBiosource | 1mg | EUR 2175 |
Recombinant Human HSPB7 |
|||
| MBS7611589-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
HSPB7 Polyclonal Antibody |
|||
| A59438 | EpiGentek |
|
|
HSPB7 Polyclonal Antibody |
|||
| ABP58826-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of HSPB7 from Human, Mouse. This HSPB7 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human HSPB7 protein at amino acid sequence of 100-180 |
|||
HSPB7 Polyclonal Antibody |
|||
| ABP58826-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of HSPB7 from Human, Mouse. This HSPB7 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human HSPB7 protein at amino acid sequence of 100-180 |
|||
HSPB7 Polyclonal Antibody |
|||
| ABP58826-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of HSPB7 from Human, Mouse. This HSPB7 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human HSPB7 protein at amino acid sequence of 100-180 |
|||
HSPB7 Polyclonal Antibody |
|||
| E-AB-92051-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
HSPB7 Polyclonal Antibody |
|||
| E-AB-92051-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
HSPB7 Polyclonal Antibody |
|||
| E-AB-92051-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
HSPB7 Polyclonal Antibody |
|||
| E-AB-92051-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
HSPB7 Conjugated Antibody |
|||
| C44809 | SAB | 100ul | EUR 476.4 |
HSPB7 Polyclonal Antibody |
|||
| BT-AP10217-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
|
Description: Belongs to the small heat shock protein (HSP20) family.,subunit:Interacts with C-terminal domain of actin-binding protein 280.,tissue specificity:Isoform 1 is highly expressed in adult and fetal heart, skeletal muscle, and at a much lower levels in adipose tissue and in aorta. Undetectable in other tissues. Isoform 2 and isoform 3 are poorly detected in heart., |
|||
HSPB7 Polyclonal Antibody |
|||
| BT-AP10217-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
|
Description: Belongs to the small heat shock protein (HSP20) family.,subunit:Interacts with C-terminal domain of actin-binding protein 280.,tissue specificity:Isoform 1 is highly expressed in adult and fetal heart, skeletal muscle, and at a much lower levels in adipose tissue and in aorta. Undetectable in other tissues. Isoform 2 and isoform 3 are poorly detected in heart., |
|||
HSPB7 Polyclonal Antibody |
|||
| BT-AP10217-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
|
Description: Belongs to the small heat shock protein (HSP20) family.,subunit:Interacts with C-terminal domain of actin-binding protein 280.,tissue specificity:Isoform 1 is highly expressed in adult and fetal heart, skeletal muscle, and at a much lower levels in adipose tissue and in aorta. Undetectable in other tissues. Isoform 2 and isoform 3 are poorly detected in heart., |
|||
HSPB7 polyclonal antibody |
|||
| BS77739 | Bioworld Biotech | 50ul | EUR 358 |
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
HSPB7 Polyclonal Antibody |
|||
| E11-201752 | EnoGene | 100ug/100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
HSPB7 Polyclonal Antibody |
|||
| JOT-AP10217-100ul | Jotbody | 100ul | EUR 220 |
HSPB7 Polyclonal Antibody |
|||
| JOT-AP10217-50ul | Jotbody | 50ul | EUR 144 |
HSPB7 Polyclonal Antibody |
|||
| E44H09359 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
HSPB7 Polyclonal Antibody |
|||
| MBS8531106-01mg | MyBiosource | 0.1mg | EUR 305 |
HSPB7 Polyclonal Antibody |
|||
| MBS8531106-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
HSPB7 Polyclonal Antibody |
|||
| MBS8531106-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
HSPB7 Polyclonal Antibody |
|||
| MBS8531106-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
HSPB7 Polyclonal Antibody |
|||
| MBS8531106-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
HSPB7 Conjugated Antibody |
|||
| MBS9452761-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
HSPB7 Conjugated Antibody |
|||
| MBS9452761-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
HSPB7 Conjugated Antibody |
|||
| MBS9452761-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
HSPB7 Conjugated Antibody |
|||
| MBS9452761-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
HSPB7 Conjugated Antibody |
|||
| MBS9452761-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
HSPB7 Polyclonal Antibody |
|||
| UB-GEN-6481 | UpingBio | 100 ul | EUR 200 |
HSPB7 ELISA KIT|Human |
|||
| EF010248 | Lifescience Market | 96 Tests | EUR 826.8 |
HSPB7 protein (His tag) |
|||
| 80R-1278 | Fitzgerald Industries International | 50 ug | Ask for price |
Mouse HSPB7 shRNA Plasmid |
|||
| 20-abx973990 | Abbexa |
|
|
Human HSPB7 shRNA Plasmid |
|||
| 20-abx958982 | Abbexa |
|
|
Human HSPB7 Protein Lysate |
|||
| MBS8413230-002mg | MyBiosource | 0.02mg | EUR 365 |
Human HSPB7 Protein Lysate |
|||
| MBS8413230-5x002mg | MyBiosource | 5x0.02mg | EUR 1410 |
Hspb7 Peptide - middle region |
|||
| MBS3230900-01mg | MyBiosource | 0.1mg | EUR 180 |
Hspb7 Peptide - middle region |
|||
| MBS3230900-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
Hspb7 antibody - middle region |
|||
| MBS3205938-01mL | MyBiosource | 0.1mL | EUR 455 |
Hspb7 antibody - middle region |
|||
| MBS3205938-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
HSPB7 Antibody, HRP conjugated |
|||
| 1-CSB-PA10979B0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against HSPB7. Recognizes HSPB7 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
HSPB7 Antibody, HRP conjugated |
|||
| MBS1495657-005mg | MyBiosource | 0.05mg | EUR 190 |
HSPB7 Antibody, HRP conjugated |
|||
| MBS1495657-01mg | MyBiosource | 0.1mg | EUR 270 |
HSPB7 Antibody, HRP conjugated |
|||
| MBS1495657-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
OPPA02311-2UG - HSPB7 Protein |
|||
| OPPA02311-2UG | Aviva Systems Biology | 2ug | EUR 70 |
HSPB7 Recombinant Protein (Rat) |
|||
| RP205271 | ABM | 100 ug | Ask for price |
HSPB7 Antibody, FITC conjugated |
|||
| 1-CSB-PA10979C0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against HSPB7. Recognizes HSPB7 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
HSPB7 Antibody, FITC conjugated |
|||
| MBS1495508-005mg | MyBiosource | 0.05mg | EUR 190 |
HSPB7 Antibody, FITC conjugated |
|||
| MBS1495508-01mg | MyBiosource | 0.1mg | EUR 270 |
HSPB7 Antibody, FITC conjugated |
|||
| MBS1495508-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
OACD04347-1ML - HSPB7 Antibody |
|||
| OACD04347-1ML | Aviva Systems Biology | 1ml | EUR 669 |
Hspb7 (NM_013868) Mouse Recombinant Protein |
|||
| E45M43483M5 | EnoGene | 20 ug | EUR 1924.54 |
Recombinant Human HSPB7 Protein |
|||
| E30P60513B | EnoGene | 50 ug | EUR 295 |
Recombinant Human HSPB7 protein |
|||
| MBS1562078-005mg | MyBiosource | 0.05mg | EUR 320 |
Recombinant Human HSPB7 protein |
|||
| MBS1562078-01mg | MyBiosource | 0.1mg | EUR 410 |
Recombinant Human HSPB7 protein |
|||
| MBS1562078-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Recombinant Human HSPB7 Protein |
|||
| MBS8249177-001mg | MyBiosource | 0.01mg | EUR 235 |
Recombinant Human HSPB7 Protein |
|||
| MBS8249177-005mg | MyBiosource | 0.05mg | EUR 510 |
Recombinant Human HSPB7 Protein |
|||
| MBS8249177-05mg | MyBiosource | 0.5mg | EUR 2210 |
Recombinant Human HSPB7 Protein |
|||
| MBS8249177-5x05mg | MyBiosource | 5x0.5mg | EUR 9850 |
OACA04222-50UG - HSPB7 Antibody |
|||
| OACA04222-50UG | Aviva Systems Biology | 50ug | EUR 179 |
HSPB7 Recombinant Protein (Human) |
|||
| RP015379 | ABM | 100 ug | Ask for price |
HSPB7 Recombinant Protein (Mouse) |
|||
| RP142652 | ABM | 100 ug | Ask for price |
HSPB7 Rabbit Polyclonal Antibody |
|||
| 54543 | SAB | 100ul | EUR 439 |
HSPB7 Antibody, Biotin conjugated |
|||
| 1-CSB-PA10979D0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against HSPB7. Recognizes HSPB7 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
HSPB7 Rabbit Polyclonal Antibody |
|||
| ES10698-100ul | ELK Biotech | 100ul | EUR 124 |
|
Description: WB, ELISA |
|||
HSPB7 Rabbit Polyclonal Antibody |
|||
| ES10698-50ul | ELK Biotech | 50ul | EUR 74 |
|
Description: WB, ELISA |
|||
HSPB7 Antibody, Biotin conjugated |
|||
| MBS1491991-005mg | MyBiosource | 0.05mg | EUR 190 |
HSPB7 Antibody, Biotin conjugated |
|||
| MBS1491991-01mg | MyBiosource | 0.1mg | EUR 270 |
HSPB7 Antibody, Biotin conjugated |
|||
| MBS1491991-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
HSPB7 Rabbit Polyclonal Antibody |
|||
| MBS9465677-005mL | MyBiosource | 0.05mL | EUR 300 |
HSPB7 Rabbit Polyclonal Antibody |
|||
| MBS9465677-01mL | MyBiosource | 0.1mL | EUR 390 |
HSPB7 Rabbit Polyclonal Antibody |
|||
| MBS9465677-5x01mL | MyBiosource | 5x0.1mL | EUR 1610 |
OACD04347-100UL - HSPB7 Antibody |
|||
| OACD04347-100UL | Aviva Systems Biology | 100ul | EUR 199 |
OACA04222-100UG - HSPB7 Antibody |
|||
| OACA04222-100UG | Aviva Systems Biology | 100ug | EUR 319 |
OAAL00642-100UG - HSPB7 Antibody |
|||
| OAAL00642-100UG | Aviva Systems Biology | 100ug | EUR 349 |
Hspb7 (untagged) - Mouse heat shock protein family, member 7 (cardiovascular) (Hspb7), (10ug) |
|||
| MC209817 | Origene Technologies GmbH | 10 µg | Ask for price |
HSPB7 (untagged)-Human heat shock 27kDa protein family, member 7 (cardiovascular) (HSPB7) |
|||
| SC320158 | Origene Technologies GmbH | 10 µg | Ask for price |
Hspb7 ORF Vector (Rat) (pORF) |
|||
| ORF068425 | ABM | 1.0 ug DNA | EUR 607.2 |
HSPB7 ORF Vector (Human) (pORF) |
|||
| ORF005127 | ABM | 1.0 ug DNA | EUR 114 |
Hspb7 ORF Vector (Mouse) (pORF) |
|||
| ORF047552 | ABM | 1.0 ug DNA | EUR 607.2 |
Mouse Hspb7 qPCR Primer Pair |
|||
| QM25662S | Beyotime Biotech Inc | 200 Tests | Ask for price |
Human HSPB7 qPCR Primer Pair |
|||
| QH38449S | Beyotime Biotech Inc | 200 Tests | Ask for price |
Hspb7 (Myc-DDK-tagged) - Mouse heat shock protein family, member 7 (cardiovascular) (Hspb7) |
|||
| MR221069 | Origene Technologies GmbH | 10 µg | Ask for price |
Hspb7 (GFP-tagged) - Mouse heat shock protein family member 7 (cardiovascular) (Hspb7), (10ug) |
|||
| MG221069 | Origene Technologies GmbH | 10 µg | Ask for price |
HSPB7 (GFP-tagged) - Human heat shock 27kDa protein family, member 7 (cardiovascular) (HSPB7) |
|||
| RG202861 | Origene Technologies GmbH | 10 µg | Ask for price |
Human HSPB7 knockout cell line |
|||
| ABC-KH7067 | AcceGen | 1 vial | Ask for price |
|
Description: Human HSPB7 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
|||
Human HSPB7 knockdown cell line |
|||
| ABC-KD7067 | AcceGen | 1 vial | Ask for price |
|
Description: Human HSPB7 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
|||
Human HSPB7 Protein Lysate 20ug |
|||
| IHUHSPB7PLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human HSPB7 Protein Lysate 20ug |
|||
HSPB7 ELISA Kit (Human) (OKCD00908) |
|||
| OKCD00908 | Aviva Systems Biology | 96 Wells | EUR 997.2 |
|
Description: Description of target: ;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.124 ng/mL |
|||
cvHSP (HSPB7) (NM_014424) Human Recombinant Protein |
|||
| E45H40642M5 | EnoGene | 20 ug | EUR 785.42 |
cvHSP (HSPB7) (NM_014424) Human Recombinant Protein |
|||
| PROTQ9UBY9 | BosterBio | Regular: 10ug | EUR 1249 |
|
Description: Recombinant protein of human heat shock 27kDa protein family, member 7 (cardiovascular) (HSPB7) |
|||
Hspb7 Peptide - C-terminal region |
|||
| MBS3230901-01mg | MyBiosource | 0.1mg | EUR 180 |
Hspb7 Peptide - C-terminal region |
|||
| MBS3230901-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
Hspb7 antibody - C-terminal region |
|||
| MBS3205939-01mL | MyBiosource | 0.1mL | EUR 455 |
Hspb7 antibody - C-terminal region |
|||
| MBS3205939-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
Hspb7 (untagged ORF) - Rat heat shock protein family, member 7 (cardiovascular) (Hspb7), (10 ug) |
|||
| RN213025 | Origene Technologies GmbH | 10 µg | Ask for price |
OCOA11141-20UG - HSPB7 Protein Lysate |
|||
| OCOA11141-20UG | Aviva Systems Biology | 20ug | EUR 169 |
HSPB7 Over-expression Lysate Product |
|||
| GWB-FD7B98 | GenWay Biotech | 0.1 mg | Ask for price |
HSPB7 (Myc-DDK-tagged)-Human heat shock 27kDa protein family, member 7 (cardiovascular) (HSPB7) |
|||
| RC202861 | Origene Technologies GmbH | 10 µg | Ask for price |
Polyclonal Hspb7 antibody - middle region |
|||
| APR00806G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Hspb7 - middle region. This antibody is tested and proven to work in the following applications: |
|||
HSPB7 Polyclonal Antibody, HRP Conjugated |
|||
| A59441 | EpiGentek |
|
|
HSPB7 Polyclonal Antibody, FITC Conjugated |
|||
| A59440 | EpiGentek |
|
|
OPCD04035-10UG - HSPB7 Recombinant Protein |
|||
| OPCD04035-10UG | Aviva Systems Biology | 10ug | EUR 139 |
OPCD04035-50UG - HSPB7 Recombinant Protein |
|||
| OPCD04035-50UG | Aviva Systems Biology | 50ug | EUR 339 |
HSPB7 Polyclonal Antibody, Biotin Conjugated |
|||
| A59439 | EpiGentek |
|
|
OPCD04035-200UG - HSPB7 Recombinant Protein |
|||
| OPCD04035-200UG | Aviva Systems Biology | 200ug | EUR 669 |
cvHSP (HSPB7) (NM_014424) Human Over-expression Lysate |
|||
| E45H09168-2 | EnoGene | each | EUR 395 |
cvHSP (HSPB7) (NM_014424) Human Over-expression Lysate |
|||
| LS027129 | BosterBio | 100ug | EUR 628 |
|
Description: Transient overexpression lysate of heat shock 27kDa protein family, member 7 (cardiovascular) (HSPB7) |
|||
OKCD00908-96W - HSPB7 ELISA Kit (Human) |
|||
| OKCD00908-96W | Aviva Systems Biology | 96Wells | EUR 675 |
Hspb7 sgRNA CRISPR Lentivector set (Rat) |
|||
| K6773301 | ABM | 3 x 1.0 ug | EUR 406.8 |
Hspb7 (Myc-DDK-tagged ORF) - Rat heat shock protein family, member 7 (cardiovascular) (Hspb7), (10 ug) |
|||
| RR213025 | Origene Technologies GmbH | 10 µg | Ask for price |
Recombinant Human HSPB7 Protein, His Tag |
|||
| E40KMH1229 | EnoGene | 20ug | EUR 495 |
Recombinant Human HSPB7 Protein (His Tag) |
|||
| PKSH032524-10ug | Elabscience Biotech | 10ug | EUR 275 |
|
Description: Human |
|||
Recombinant Human HSPB7 Protein (His Tag) |
|||
| PKSH032524-50ug | Elabscience Biotech | 50ug | EUR 525 |
|
Description: Human |
|||
Recombinant Human HSPB7 Protein, His Tag |
|||
| KMH1229 | KMD Bioscience |
|
|
HSPB7, 1-170aa, Human, His tag, E Coli |
|||
| MBS203412-001mg | MyBiosource | 0.01mg | EUR 230 |
HSPB7, 1-170aa, Human, His tag, E Coli |
|||
| MBS203412-005mg | MyBiosource | 0.05mg | EUR 405 |
HSPB7, 1-170aa, Human, His tag, E Coli |
|||
| MBS203412-025mg | MyBiosource | 0.25mg | EUR 985 |
HSPB7, 1-170aa, Human, His tag, E Coli |
|||
| MBS203412-5x025mg | MyBiosource | 5x0.25mg | EUR 4180 |
HSPB7 sgRNA CRISPR Lentivector set (Human) |
|||
| K0999601 | ABM | 3 x 1.0 ug | EUR 406.8 |
Hspb7 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3968001 | ABM | 3 x 1.0 ug | EUR 406.8 |
Lenti ORF clone of Hspb7 (mGFP-tagged) - Mouse heat shock protein family, member 7 (cardiovascular) (Hspb7) |
|||
| MR221069L4 | Origene Technologies GmbH | 10 µg | Ask for price |
AAP41600-100UG - Hspb7 Peptide - middle region |
|||
| AAP41600-100UG | Aviva Systems Biology | 100ug | EUR 99 |
Hspb7 3'UTR GFP Stable Cell Line |
|||
| TU256020 | ABM | 1.0 ml | Ask for price |
Hspb7 3'UTR GFP Stable Cell Line |
|||
| TU159809 | ABM | 1.0 ml | Ask for price |
HSPB7 3'UTR GFP Stable Cell Line |
|||
| TU060269 | ABM | 1.0 ml | EUR 5540.4 |
Polyclonal Hspb7 antibody - C-terminal region |
|||
| APR00807G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Hspb7 - C-terminal region. This antibody is tested and proven to work in the following applications: |
|||
ARP41600_P050-25UL - Hspb7 Antibody - middle region |
|||
| ARP41600_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
HSPB7 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV273700 | ABM | 500 ng | EUR 723.6 |
Lenti ORF clone of Hspb7 (Myc-DDK-tagged) - Mouse heat shock protein family, member 7 (cardiovascular) (Hspb7) |
|||
| MR221069L3 | Origene Technologies GmbH | 10 µg | Ask for price |
ARP41600_P050 - Hspb7 antibody - middle region (ARP41600_P050) |
|||
| ARP41600_P050 | Aviva Systems Biology | 100ul | EUR 389 |
HSPB7 Protein Vector (Rat) (pPB-C-His) |
|||
| PV273698 | ABM | 500 ng | EUR 723.6 |
HSPB7 Protein Vector (Rat) (pPB-N-His) |
|||
| PV273699 | ABM | 500 ng | EUR 723.6 |
HSPB7 Protein Vector (Rat) (pPM-C-His) |
|||
| PV273701 | ABM | 500 ng | EUR 723.6 |
HSPB7 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV190208 | ABM | 500 ng | EUR 723.6 |
HSPB7 Protein Vector (Human) (pPM-C-HA) |
|||
| PV020507 | ABM | 500 ng | EUR 394.8 |
HSPB7 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV190206 | ABM | 500 ng | EUR 723.6 |
In all ethnic teams in Kyrgyzstan, people with CVD had elevated odds of sleep disturbance and burnout. There was a major distinction in burnout and stress between individuals with and with out CVD in Kyrgyz and East European ethnic teams. Conclusion: There was a major distinction in burnout and stress between individuals with and with out CVD in Kyrgyz and East European ethnic teams. Along with CVD prevention, mitigating sleep disturbance and stopping burnout within the normal inhabitants must be geared toward in public well being measures.
